Literature DB >> 8097996

Withdrawal symptoms from high dose benzodiazepines in poly drug users.

N Seivewright1, W Dougal.   

Abstract

Among poly drug users attending a treatment service, 33 subjects were identified who had experienced withdrawal symptoms from high dose benzodiazepines (median diazepam equivalent 140 mg/day) at a time uncomplicated by simultaneous cessation of other drugs. Symptoms were rated using the Benzodiazepine Withdrawal Symptom Questionnaire (Tyrer et al. (1990) The Benzodiazepine Withdrawal Symptom Questionnaire. J. Affective Disorders, 19, 53-61). The symptoms experienced were similar to those described in studies of withdrawal from low dose benzodiazepines, but more severe. Greater severity of symptoms was significantly associated with high dosage, the use of multiple benzodiazepines and oral rather than injected use. The implications for clinical management are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097996     DOI: 10.1016/0376-8716(93)90018-l

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  4 in total

Review 1.  Benzodiazepine dependence. Avoidance and withdrawal.

Authors:  S Marriott; P Tyrer
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 2.  Benzodiazepine dependence and its treatment with low dose flumazenil.

Authors:  Sean David Hood; Amanda Norman; Dana Adelle Hince; Jan Krzysztof Melichar; Gary Kenneth Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal.

Authors:  Michael Liebrenz; Marie-Therese Gehring; Anna Buadze; Carlo Caflisch
Journal:  BMC Psychiatry       Date:  2015-05-13       Impact factor: 3.630

Review 4.  Benzodiazepine high-doses: The need for an accurate definition.

Authors:  Jean-Marc Cloos; Christopher Y S Lim Cow; Valéry Bocquet
Journal:  Int J Methods Psychiatr Res       Date:  2021-07-31       Impact factor: 4.035

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.